Flowserve posts Q4 loss per share on $140 million asbestos charge; sales up 3.5%
Flowserve reported fourth quarter 2025 net loss attributable to the company of $29.0 million, or $0.23 per diluted share, versus earnings of $0.59 per share a year earlier, after a $140.1 million loss on divesting asbestos-related assets and liabilities. Adjusted EPS rose to $1.11 from $0.70, and sales rose 3.5% to $1.22 billion. The company also initiated 2026 guidance for adjusted EPS of $4.00 to $4.20 and agreed to buy Trillium Flow Technologies' Valves Division for $490 million in cash, with closing expected mid-year 2026.
Key points
- Q4 2025 reported EPS was a loss of $0.23 versus $0.59 in Q4 2024; adjusted EPS was $1.11 versus $0.70.
- Full year 2025 sales were $4.73 billion, up 3.8%, and full year diluted EPS was $2.64 versus $2.14.
- 2026 guidance: total sales growth of 5% to 7% and adjusted EPS of $4.00 to $4.20.
- Trillium Valves acquisition for $490 million in cash, subject to customary closing conditions and regulatory approvals, with closing expected mid-year 2026.
The filing
Written by AI on Nov 8, 2026, 12:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.